{"chebi_id":"28748","chebi_name":"doxorubicin","chebi_synonyms":["(1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-\u03b1-L-lyxo-hexopyranoside","Adriamycin","14-hydroxydaunomycin","14-hydroxydaunorubicine","Doxorubicin","(8S-cis)-10-((3-amino-2,3,6-trideoxy-\u03b1-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione","doxorubicinum","doxorubicine","DOXORUBICIN","(1S,3S)-3-glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-\u03b1-L-lyxo-hexopyranoside"],"diffprof_id_observed":["MTBLS2825_0002_00000004","MTBLS3963_0001_00000001","MTBLS5195_0001_00000001","MTBLS5877_0001_00000002"],"diffprof_id_var_observed":[],"inchikey":"AOJJSUZBOXZQNB-TZSSRYMLSA-N","inn_name":"doxorubicine","iupac_name":"(1<i>S</i>,3<i>S</i>)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-\u03b1-<small>L</small>-<i>lyxo</i>-hexopyranoside","num_study_observed":4,"reactome_ids":["R-HSA-1430728","R-HSA-211859","R-HSA-211945","R-HSA-382551","R-HSA-382556","R-HSA-9748784","R-HSA-9757110"],"reactome_names":["Metabolism","Biological oxidations","Phase I - Functionalization of compounds","Transport of small molecules","ABC-family proteins mediated transport","Drug ADME","Prednisone ADME"],"study_id_observed":["MTBLS2825","MTBLS3963","MTBLS5195","MTBLS5877"],"study_id_var_observed":[],"synonym_name":"Adriamycin"}